FRANZE', Maria Stella
 Distribuzione geografica
Continente #
EU - Europa 1.779
NA - Nord America 1.468
AS - Asia 855
SA - Sud America 236
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 36
OC - Oceania 2
Totale 4.489
Nazione #
US - Stati Uniti d'America 1.428
RU - Federazione Russa 1.012
SG - Singapore 323
IT - Italia 246
CN - Cina 230
BR - Brasile 192
IE - Irlanda 170
SE - Svezia 93
HK - Hong Kong 83
DE - Germania 73
VN - Vietnam 52
IN - India 48
FR - Francia 35
PL - Polonia 30
BD - Bangladesh 27
GB - Regno Unito 27
CA - Canada 24
FI - Finlandia 22
AR - Argentina 18
AT - Austria 18
NL - Olanda 16
ID - Indonesia 12
JP - Giappone 12
ZA - Sudafrica 12
UZ - Uzbekistan 11
PK - Pakistan 10
MX - Messico 9
TR - Turchia 9
CO - Colombia 7
CZ - Repubblica Ceca 6
VE - Venezuela 6
BE - Belgio 5
EC - Ecuador 5
IL - Israele 5
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
MA - Marocco 4
CI - Costa d'Avorio 3
ES - Italia 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GA - Gabon 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UA - Ucraina 1
UY - Uruguay 1
Totale 4.376
Città #
Ashburn 305
Moscow 291
Singapore 172
Dallas 171
Dublin 170
San Jose 110
Chandler 106
Messina 101
Hong Kong 82
Nyköping 66
Council Bluffs 49
The Dalles 48
Beijing 44
Munich 36
Los Angeles 31
Warsaw 28
New York 27
Lauterbourg 22
Hyderabad 19
São Paulo 18
Tianjin 18
Redondo Beach 16
Princeton 15
Santa Clara 15
Avola 13
Catania 13
Hanoi 13
Medford 13
Nuremberg 13
Orem 13
Amsterdam 12
Ann Arbor 11
Buffalo 11
Frankfurt am Main 11
Tokyo 11
Des Moines 10
Vienna 10
Columbus 9
Dearborn 9
Helsinki 9
Tashkent 9
Atlanta 8
Brooklyn 8
Jakarta 8
Shanghai 8
Chennai 7
Ho Chi Minh City 7
Jacksonville 7
Johannesburg 7
Rio de Janeiro 7
Turku 7
Denver 6
Guangzhou 6
Haiphong 6
Montreal 6
Pune 6
Rome 6
Stockholm 6
Brasília 5
Brussels 5
Islamabad 5
Lappeenranta 5
Milan 5
New Delhi 5
Pachino 5
Seattle 5
Shenzhen 5
Sorocaba 5
Baghdad 4
Boardman 4
Bremen 4
Cambridge 4
Dong Ket 4
Jinan 4
London 4
Mexico City 4
Nanjing 4
Phoenix 4
Poplar 4
San Francisco 4
Tel Aviv 4
Abidjan 3
Amman 3
Barnet 3
Belo Horizonte 3
Campinas 3
Cape Town 3
Curitiba 3
Da Nang 3
Dhaka 3
Esmeraldas 3
Fino Mornasco 3
Haikou 3
Houston 3
Lahore 3
Mumbai 3
Muscat 3
Prague 3
Salvador 3
San Mateo 3
Totale 2.425
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 276
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 272
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 265
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 215
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 198
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 195
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 190
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 177
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 176
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 170
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 167
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 165
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 164
Monofocal hepatocellular carcinoma: How much does size matter? 152
Pattern of macrovascular invasion in hepatocellular carcinoma 148
Natural course of COVID-19 and independent predictors of mortality 148
Characterization of the intrahepatic immune microenvironment and gene expression profile in hepatitis B and hepatocellular carcinoma 146
The changing scenario of hepatocellular carcinoma in Italy: an update 146
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 137
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 120
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 117
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 115
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 109
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 103
Hepatitis Delta Virus and Hepatocellular Carcinoma 102
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 95
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 79
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 77
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression 33
null 20
Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy 12
Totale 4.489
Categoria #
all - tutte 14.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 10 2 4 7 6 17 1 4 16 19 35
2022/2023419 23 48 16 28 29 38 7 24 190 3 12 1
2023/2024145 7 16 3 16 9 30 0 10 1 30 4 19
2024/2025887 5 27 30 50 94 51 66 151 182 57 78 96
2025/20262.539 138 168 193 174 200 478 289 307 338 141 64 49
2026/2027240 73 167 0 0 0 0 0 0 0 0 0 0
Totale 4.489